OwnershipPublicly listed · Nasdaq: NXLSEC EDGAR company record and tickers file (Nasdaq: NXL) · checked Oct 28, 2026
Commercial developmentNot yet assessedWe only state a stage once a source supports it. Having a product on sale does not show it works or makes money.
Investment accessVerified public listingListed as Nasdaq: NXL, per the SEC's company tickers file. A listing means shares trade publicly; it says nothing about whether they are a good investment.Source · checked Oct 28, 2026
Evidence is labelled on each development below (company-reported, regulatory filing or government record), not on the company as a whole. Next scheduled recheck: Nov 27, 2026.
11developments published
—US federal obligations on record
0federal awards
Sep 28, 2026latest development
Timeline
- Sep 28, 2026 · Material agreement
Nexalin Technology Signs Definitive Exclusive Distribution and Local Manufacturing Agreement for Brazil and South America, Marking a Major Step in Its Transition Toward Commercial Revenue Generation
Company-reported - Sep 25, 2026 · Listing notice
Nexalin Technology reports a notice about its stock exchange listing (Form 8-K, Item 3.01)
Regulatory filing - Aug 28, 2026 · Leadership change
Nexalin Technology reports changes involving its directors or officers (Form 8-K, Item 5.02)
Regulatory filing - Aug 26, 2026 · Company announcement
Nexalin Technology Announces Reverse Stock Split
Company-reported - Aug 21, 2026 · Financing
Nexalin Technology reports entry into a material definitive agreement (Form 8-K, Item 1.01)
Regulatory filing - Aug 19, 2026 · Financing
Nexalin Technology reports entry into a material definitive agreement (Form 8-K, Item 1.01)
Regulatory filing - Aug 14, 2026 · Listing notice
Nexalin Technology reports a notice about its stock exchange listing (Form 8-K, Item 3.01)
Regulatory filing - Aug 11, 2026 · Shareholder vote
Nexalin Technology reports results of a shareholder vote (Form 8-K, Item 5.07)
Regulatory filing - Jul 24, 2026 · Listing notice
Nexalin Technology reports a notice about its stock exchange listing (Form 8-K, Item 3.01)
Regulatory filing - Jun 16, 2026 · Governance change
Nexalin Technology reports amendments to its charter or bylaws (Form 8-K, Item 5.03)
Regulatory filing - May 14, 2026 · Financing
Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO™ Clarity and Nexalin NeuroCare™ Ahead of Planned FDA Pivotal Trial
Company-reported
Profile
- Legal name
- Nexalin Technology, Inc.
- Listing
- Nasdaq NXL
- SEC filer
- CIK 0001527352 ↗
- SEC industry code
- Electromedical & Electrotherapeutic Apparatus
- Incorporated
- DE
- Coverage
- Filings + federal awards
Mix of developments
Watch Nexalin Technology
Anything new from Nexalin Technology lands in your digest, with the source beside it. Following is about information, never an investment action. Up to 10 companies or frontiers on Pro, $49/month.
Follow this companyPreview a sample digest